Synthesis and antimicrobial activity of novel tetrahydrobenzothienopyrimidines

被引:13
作者
Haleem, AA
Eissa, M
Moneer, AA
机构
[1] Cairo Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo 11562, Egypt
[2] Cairo Univ, Fac Pharm, Dept Organ Chem, Cairo 11562, Egypt
关键词
2-substituted or unsubstituted-4-[(4-substituted)anilino] tetrahydrobenzothienopyrimidine derivatives; antimicrobial activity;
D O I
10.1007/BF02975838
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Due to the rapidly growing number of resistant strains of bacteria, the search for antibacterial agents with new modes of action will always remain an important and challenging task. Thus, the reaction of 2-substituted or unsubstituted-4-(4-acetylanilino)-5,6,7,8-terahydrobenzo[b] thieno[2,3-d]pyrimidine derivatives 1-3 with the hydrazine derivatives, semi and / or thiosemicarbazides, provided the corresponding hydrazones 4-6 and semi and/or thiosemicarbazones 7-9. Claisen-Schmidt condensation of compounds 1 or 2 with the appropriate aldehyde yielded the chalcones 10, 11 which, when treated with hydroxylamine hydrochloride gave rise to the isoxazoline-containing compounds 12, 13. Furthermore, reacting the respective chalcones 10, 11 with different hydrazines, urea and/or thiourea, furnished compounds 14, 15, 16, and 17 respectively. Representative compounds were tested for their antimicrobial activity against Candida Albicans and certain gram-positive and gram-negative bacteria. Their MICs were then determined. Compound 15e, showed a broad spectrum of activity while most of the other compounds showed varying antimicrobial activity.
引用
收藏
页码:885 / 892
页数:8
相关论文
共 26 条
[1]  
ABOULWAFA OM, 1992, FARMACO, V47, P631
[2]  
ABOUOUF AA, 1979, J DRUG RES EGYPT, V11, P73
[3]  
BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
[4]  
BODNAR AL, 2002, 224 ACS NAT M BOST M
[5]  
COLLINS CH, 1976, MICROBIOLOGICAL METH, P92
[6]  
EISA H M, 1990, Pakistan Journal of Scientific and Industrial Research, V33, P417
[7]  
El-Enany M. M, 1989, ORIENT J CHEM, V5, P114, DOI [10.1016/j.ejmech.2010.08.044, DOI 10.1016/J.EJMECH.2010.08.044]
[8]  
El-Kerdawy Mohamed M., 1993, Chinese Pharmaceutical Journal, V45, P457
[9]  
ERIK NK, 1981, CHEM SCR, V18, P135
[10]  
GANGIEE A, 2003, 225 ACS NAT M NEW OR